Amgen (AMGN) presents positive top-line results from the Phase 3 MINT trial
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq futures drop over 1% as AI worries resurface, oil climbs
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
| Amgen Inc (NASDAQ: AMGN) | Delayed: 438.34 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $438.34 | 52 Week High | $176.85 | |||
| Open | $438.34 | 52 Week Low | $133.64 | |||
| Day High | $438.34 | P/E | 66.02 | |||
| Day Low | $438.34 | EPS | $6.64 | |||
| Volume | 6,872 | |||||
